HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A precricoid swelling in a patient treated with Teflon injection in the vocal fold after idiopathic left vocal fold palsy.

AbstractVocal fold palsy is a cause of dysphonia. Due to incomplete glottic closure during phonation, patients with a unilateral vocal fold palsy present with a weak and breathy voice and recurrent aspiration. To lessen the clinical manifestations of unilateral vocal fold palsy, polytetrafluoroethylene (Teflon) paste is one agent which has been injected into the paraglottic region, thus causing the vocal fold to move more medially. One of the complications associated with Teflon paste injection is migration of the paste into the surrounding tissues. We present a patient with idiopathic left vocal fold palsy who underwent Teflon injection to the vocal fold and subsequently developed a precricoid nodule, mimicking a cartilaginous swelling.
AuthorsJ A Jol, R Y Seedat, D W Skinner (Affiliation: Department of Otorhinolaryngology-Head and Neck Surgery, Royal Shrewsbury Hospitals NHS Trust, UK.)
JournalThe Journal of laryngology and otology (J Laryngol Otol) Vol. 112 Issue 9 Pg. 878-9 (Sep 1998) ISSN: 0022-2151 [Print] ENGLAND
PMID9876383 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Polytetrafluoroethylene
Topics
  • Aged
  • Cricoid Cartilage
  • Female
  • Foreign-Body Migration (radiography)
  • Humans
  • Injections, Intralesional
  • Polytetrafluoroethylene (administration & dosage)
  • Tomography, X-Ray Computed
  • Vocal Cord Paralysis (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD